<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01871220</url>
  </required_header>
  <id_info>
    <org_study_id>201302798</org_study_id>
    <nct_id>NCT01871220</nct_id>
  </id_info>
  <brief_title>Periimplant Mucosa Dynamics Around Divergent and Concave Atlantis Abutment Transition Profiles</brief_title>
  <official_title>Peri-implant Mucosa Dynamics Around Divergent and Concave Atlantis™ Abutment Transition Profiles.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christopher Barwacz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of two different implant abutment designs&#xD;
      on gum tissue volume changes over time after implant placement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, prospective, controlled clinical trial comparing the facial gingival&#xD;
      profiles around Atlantis™ abutments that have either a linear &quot;divergent&quot; or &quot;concave&quot;&#xD;
      transitional profile on the facial and proximal aspect of the abutments.&#xD;
&#xD;
      Sixty study subjects requiring replacement of a single-rooted tooth with an implant-supported&#xD;
      restoration will be recruited.&#xD;
&#xD;
      The Osseospeed™ Plus implant will be placed for all 60 subjects, with the use of Uni healing&#xD;
      abutments to minimize lateral tissue displacement during healing. After implant placement,&#xD;
      but before final impressions are obtained (8 weeks post-placement), subjects will be&#xD;
      randomized to either a &quot;divergent&quot; or a &quot;concave&quot; transmucosal abutment design. For&#xD;
      fabrication of the experimental abutment, Atlantis™ engineers will initially design a control&#xD;
      &quot;divergent&quot; prototype that will be modified with a concavity on the facial and proximal&#xD;
      transition zones to obtain an abutment that will otherwise retain all the features of the&#xD;
      control abutment. Engineers will measure the linear topographical changes (ΔL=Lc-Ld) of the&#xD;
      transition zone, as well as the volumetric change (x) on the mid-facial aspect of the&#xD;
      abutment induced by the formation of a submucosal concavity. The primary outcome of the study&#xD;
      will be the apico-coronal change of the peri-implant mucosal zenith from prosthesis delivery&#xD;
      to one year.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 30, 2013</start_date>
  <completion_date type="Actual">October 3, 2018</completion_date>
  <primary_completion_date type="Actual">October 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peri-Implant Mucosal Zenith Changes</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Apico-coronal changes of the peri-implant mucosal zenith from prosthesis delivery to one year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of bucco-linqual soft tissue thickness</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Submarginal bucco-lingual soft tissue thickness in the peri-implant transition zone relative to a fixed reference point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of the soft tissue interface</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Quantification of the topographical and volumetric features of the interface between the peri-implant mucosa and the transition zone.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Keratinized mucosa width</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Keratinized mucosa width in an apicocoronal direction at the midfacial aspect of the implant site.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival and Plaque Index, Bleeding on Probing, and Probing Pocket Depths</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Gingival Index (GI), Plaque Index (PI), Bleeding on probing (BOP) and probing pocket depths (PPD) at six sites (disto-lingual, mesio-lingual, mid-lingual, mesio-buccal, disto-buccal, mid-buccal).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Dental Implant, Single-Tooth</condition>
  <condition>Esthetics, Dental</condition>
  <arm_group>
    <arm_group_label>Divergent Abutment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Divergent Transition Profile</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Concave Abutment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Concave Transition Profile</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Concave Transition Profile</intervention_name>
    <description>An Atlantis abutment is delivered with a concave transition profile.</description>
    <arm_group_label>Concave Abutment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Divergent Transition Profile</intervention_name>
    <description>An Atlantis abutment is delivered with a linear transition profile</description>
    <arm_group_label>Divergent Abutment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or greater&#xD;
&#xD;
          -  Subjects requiring replacement of a single-rooted tooth in the maxillary arch from&#xD;
             first premolar to first premolar with an implant-supported restoration&#xD;
&#xD;
          -  Teeth adjacent (mesial and distal) to study site must consist of two stable, natural&#xD;
             teeth without signs of periodontal bone loss (&lt;2.0mm) and/or significant soft tissue&#xD;
             loss&#xD;
&#xD;
          -  An opposing dentition with teeth, implants, or fixed prosthesis&#xD;
&#xD;
          -  Subjects must be willing to follow instructions related to the study procedures&#xD;
&#xD;
          -  Subjects must have read, understood, and signed the informed consent document&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Insufficient interocclusal space for implant placement and/or restoration at study&#xD;
             site&#xD;
&#xD;
          -  More than 2.0mm vertical bone loss at study site as measured from the mid-buccal crest&#xD;
             of the bone on the adjacent teeth&#xD;
&#xD;
          -  Untreated rampant caries&#xD;
&#xD;
          -  Tobacco use free for ≤ 6 months&#xD;
&#xD;
          -  Liver or kidney disfunction/failure&#xD;
&#xD;
          -  Active severe infectious diseases that may affect normal healing and/or bone&#xD;
             metabolism (e.g. AIDS)&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Current alcohol or drug abuse&#xD;
&#xD;
          -  Need for systemic corticosteroids or any other medication that would influence&#xD;
             post-operative healing and/or osseointegration&#xD;
&#xD;
          -  History of relevant head/neck cancer and/or radiation of the head/neck&#xD;
&#xD;
          -  Subjects who currently use bisphosphonates or have a history of bisphosphonate use&#xD;
&#xD;
          -  Subjects with metabolic bone diseases such as osteoporosis or Paget's disease of bone&#xD;
&#xD;
          -  Known pregnancy or nursing mothers&#xD;
&#xD;
          -  Unable or unwilling to return for follow-up visits for a period of 1 year&#xD;
&#xD;
          -  Unlikely to be able to comply with study procedures according to investigators&#xD;
             judgement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris A Barwacz, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa College of Dentistry</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>June 3, 2013</study_first_submitted>
  <study_first_submitted_qc>June 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2013</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Christopher Barwacz</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Implant Abutments</keyword>
  <keyword>Oral Mucosa Changes</keyword>
  <keyword>Implant Esthetics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

